Skip to main content

March 2017

 

 

academics

 

Clinical research courses

Catalyst Pharmaceuticals Inc. a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare neuromuscular and neurological diseases, today announced positive top-line results from the investigator-sponsored trial evaluating Firdapse® (Amifampridine Phosphate) as a treatment for myasthenia gravis patients with anti-MuSK antibodies (MuSK-MG). MuSK-MG, is an ultra-rare sub-population of myasthenia Gravis (MG) patients which is a debilitating neuromuscular disease, and there are currently no FDA approved therapies for this specific form of MG.  Both of the co-primary efficacy endpoints of change from baseline (CFB) in total Quantitative Myasthenia Gravis (QMG) score (p=0.0003) and CFB in total Myasthenia Gravis Activities of Daily Living (MG-ADL) score (p=0.0006) were statistically and clinically significant in this seven patient trial.  Several secondary efficacy measures also achieved statistical significance.  Amifampridine phosphate was well tolerated in this population of patients.

Arbutus Biopharma Corporation an industry-leading therapeutic solutions company focused on developing a cure for chronic hepatitis B virus (HBV) infection announced it has licensed to Alexion Pharmaceuticals, Inc.  its proprietary lipid nanoparticle (LNP) technology for exclusive use in one of Alexion’s rare disease programs. This transaction enables Alexion to address delivery for therapeutic application of messenger RNA (mRNA) and rapidly enter clinical development with its mRNA product candidate.

Faculty Recruitment at Jamia College of Pharmacy - 16 posts | Permanent Job

The Jamia Islamia Isha-atul Uloom’s, Akkalkuwa was established in the year 1980 with the auspicious hands of honorable Maulana Gulam Mohammad Vastanvi Sahab and his devoting companions with an aim to provide moral & spiritual education in Arabic, Persian & English Language to all students without difference of cast, clout & creed.

Post : Faculty

National Conference On RECENT ADVANCEMENTS IN PHARMACEUTICAL SCIENCES AND CLINICAL RESEARCH at GALGOTIAS UNIVERSITY

GALGOTIAS UNIVERSITY
Galgotias University has been transcending new boundaries in education, research and placements since its inception in 2011. The University, which is based in Greater Noida. has an enrollment of over 15.000 students across more than 80 Undergraduate and Post Graduate programs. Galgotias has very recently been ranked 6th by India Today among top 10 emerging institutions of India (as per its issue dated May 30th 2016). Previously too. Galgotias University has been ranked among the top institutions of India by leading media surveys. Galgotias University has also been awarded for excellence in academics and placement by Dataquest Cybermedia at the Dataquest Cybermedia ICT Awards 2016. Galgotias has also been ranked No.2 among Emerging Engineering Institutes m India by limes Engineering Survey. 2016 while its School of Business has been awarded among top 5 B.Schools by Times B.School Ranking 2016.

Recruitment for M.Pharm, M.Sc as Quinologist at PSCW | Government Job

Applications in the prescribed format given at the Commission’s website at pscwbonline.gov.in. are invited from Indian citizens and such other nationals as are declared eligible by Govt. of India for recruitment to the under mentioned posts. The post at sl. no. 1 is temporary and rest of the posts are temporary but likely to be permanent.

Vacancy for Pharmacist under NUHM | Government Job

National Urban Health Mission (NUHM), Jalgaon Mahanagarpalika, Jalgaon Published Notification for the post of Pharmacist. Candidates who are Interested in this recruitment they can send application form between 11th March 2017 to 17th March 2017 with all relevant document at given address.

Post : Pharmacist

Walk in interview for Jr. Analyst and Jr. Chemist at in Quality Control Laboratory at TBI

Tea is one of the industries, which by an Act of Parliament comes under the control of the Union Govt. The genesis of the Tea Board India dates back to 1903 when the Indian Tea Cess Bill was passed. The Bill provided for levying a cess on tea exports - the proceeds of which were to be used for the promotion of Indian tea both within and outside India. The present Tea Board set up under section 4 of the Tea Act 1953 was constituted on 1st April 1954.

A walk-in-interview will be held on 24th March, 2017 as per following schedule from 11.00 a.m. onward at Quality Control Laboratory, Tea Board, Tea Park, Siliguri for engaging two contractual manpower as per followings to work in Quality Control Laboratory, Tea Park, Siliguri purely on temporary basis initially for a period of one year, which may be extended based on performance.

FORMULATION AND IN-VITRO EVALUATION OF MOUTH DISSOLVING TABLETS OF KETOPROFEN: EFFECT OF DISINTEGRANTS ON DRUG RELEASE

{ DOWNLOAD AS PDF }

ABOUT AUTHORS
Kambham Venkateswarlu*,
Department of Pharmaceutics,
JNTUA-Oil Technological and Pharmaceutical Research Institute
Andhra Pradesh,  India
k.v.reddy9441701016@gmail.com

ABSTRACT 
The objective of the present investigation was to formulate and evaluate the mouth dissolving tablets (MDTs) of ketoprofen (KPN) using disintegrants like Crospovidone (CP), Croscarmellose sodium (CCS) and Sodium starch glycolate (SSG) and the effect of disintegrants on drug release was also studied. The powder blend was evaluated for flow properties and found acceptable flow properties. The prepared MDTs were evaluated for post compression parameters such as hardness, friability, weight variation, dispersion time, drug content and in-vitro drug release. Tablets possessing sufficient strength supported by hardness and friability results. The formulation KP6 showed lease dispersion time of 14 sec and it was selected for drug release studies. KP6 showed 99.9% of drug release in 5 min and time taken for 70% of the drug is 2.8 min. Based on the results obtained from the dispersion time and in-vitro dissolution studies, it could be concluded that the concentration of disintegrant is indirectly proportional to the dispersion time and directly proportional to the amount of drug release respectively.

Opening for Manager / Sr. Manager - Procurement at JBCPL

J. B. Chemicals & Pharmaceuticals Ltd. (JBCPL), known to many as Unique Pharmaceutical Laboratories is one of India's leading global pharmaceutical companies. The company manufactures and markets a wide range of pharmaceutical formulations.

Post : Manager / Sr. Manager - Procurement (contract Mfg / Outsourcing)

Career in Healthcare Research as Supervisory Associate at Ernst & Young Global Limited

Ernst & Young refers to one or more of the member firms of Ernst & Young Global Limited (EYG), a UK private company limited by guarantee. EYG is the principal governance entity of the global Ernst & Young organization and does not provide any service to clients. Services are provided by EYG member firms. Each of EYG and its member firms is a separate legal entity and has no liability for another such entity's acts or omissions. Certain content on this site may have been prepared by one or more EYG member firms.

Post : Supervisory Associate- Healthcare Research - GSS003QG